\-\ Texto\\:\\ \ \(0\)\
\-\ elevated\\ ana\\ and\\ rf\ \(0\)\
\-\ decreased\\ breath\\ sounds\\ at\\ the\\ bases\ \(1\)\
\-\ bibasilar\\ predominance\\ of\\ septal\\ thickening\\,\\ volume\\ loss\\,\\ and\\ loss\\ of\\ normal\\ architecture\\.\ \(0\)\
\-\ interstitial\\ lung\\ disease\ \(17\)\
\-\ any\\ fibrotic\\ process\\ that\\ is\\ predominantly\\ at\\ the\\ lung\\ bases\\ including\\ asbestosis\\,\\ drug\\ induced\\ ild\\,\\ berylliosis\\,\\ connective\\ tissue\\ disorders\\,\\ ipf\\.\ \(0\)\
\-\ 55\\ year\\ old\\ with\\ long\\ history\\ of\\ rheumatoid\\ arthritis\\ on\\ disease\\ modifying\\ rheumatoid\\ arthritis\\ drug\\ regimine\\ presents\\ with\\ progressing\\ shortness\\ of\\ breath\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bases\\:\\ 0\\.1285182313484782\ \(0\)\
\-\ regimine\\:\\ 0\\.11599366347324339\ \(0\)\
\-\ drug\\:\\ 0\\.11538688487166274\ \(0\)\
\-\ ild\\:\\ 0\\.10687330583429674\ \(0\)\
\-\ modifying\\:\\ 0\\.10687330583429674\ \(0\)\
\-\ rheumatoid\\:\\ 0\\.10622091923302548\ \(0\)\
\-\ ipf\\:\\ 0\\.09775294819535009\ \(0\)\
\-\ arthritis\\:\\ 0\\.09607190658007853\ \(0\)\
\-\ berylliosis\\:\\ 0\\.0948168488359526\ \(0\)\
\-\ breath\\:\\ 0\\.08408204100656179\ \(0\)\
\-\ fibrotic\\:\\ 0\\.08036142398505641\ \(0\)\
\-\ asbestosis\\:\\ 0\\.08036142398505641\ \(0\)\
\-\ rf\\:\\ 0\\.07871454052513528\ \(0\)\
\-\ architecture\\:\\ 0\\.07725104532631655\ \(0\)\
\-\ ana\\:\\ 0\\.0765761335580593\ \(0\)\
\-\ progressing\\:\\ 0\\.07417716570550727\ \(0\)\
\-\ bibasilar\\:\\ 0\\.07262738892055486\ \(0\)\
\-\ predominance\\:\\ 0\\.07039187527851015\ \(0\)\
\-\ induced\\:\\ 0\\.06745577591911264\ \(0\)\
\-\ connective\\:\\ 0\\.06620169460589785\ \(0\)\
\-\ loss\\:\\ 0\\.06527537295969578\ \(0\)\
\-\ lung\\:\\ 0\\.06513576632207227\ \(0\)\
\-\ septal\\:\\ 0\\.0612715176395635\ \(0\)\
\-\ interstitial\\:\\ 0\\.05501038731232714\ \(0\)\
\-\ 55\\:\\ 0\\.05450907354611304\ \(0\)\
\-\ disorders\\:\\ 0\\.053791192174396804\ \(0\)\
\-\ volume\\:\\ 0\\.05311045961651274\ \(0\)\
\-\ predominantly\\:\\ 0\\.052675448270974735\ \(0\)\
\-\ shortness\\:\\ 0\\.04730477103800228\ \(0\)\
\-\ sounds\\:\\ 0\\.044846666480347096\ \(0\)\
\-\ process\\:\\ 0\\.04329033532677255\ \(0\)\
\-\ including\\:\\ 0\\.04059761369727531\ \(0\)\
\-\ long\\:\\ 0\\.03876607251095689\ \(0\)\
\-\ elevated\\:\\ 0\\.038148899491566614\ \(0\)\
\-\ thickening\\:\\ 0\\.03811348118017568\ \(0\)\
\-\ disease\\:\\ 0\\.03675625108462379\ \(0\)\
\-\ any\\:\\ 0\\.03540572411937228\ \(0\)\
\-\ decreased\\:\\ 0\\.03343100529900736\ \(0\)\
\-\ at\\:\\ 0\\.03046745139030613\ \(0\)\
\-\ tissue\\:\\ 0\\.02665027879542886\ \(0\)\
\-\ presents\\:\\ 0\\.02296900388826218\ \(0\)\
\-\ \\,\\:\\ 0\\.021371847277680583\ \(0\)\
\-\ that\\:\\ 0\\.019420799059984516\ \(0\)\
\-\ normal\\:\\ 0\\.017626479665777645\ \(0\)\
\-\ history\\:\\ 0\\.01552913865404057\ \(0\)\
\-\ year\\:\\ 0\\.012580332490433088\ \(0\)\
\-\ old\\:\\ 0\\.011512297327134928\ \(0\)\
\-\ on\\:\\ 0\\.009524881741650369\ \(0\)\
\-\ is\\:\\ 0\\.007398562873483232\ \(0\)\
\-\ of\\:\\ 0\\.006131778989367812\ \(0\)\
\-\ and\\:\\ 0\\.0047370790982162745\ \(0\)\
\-\ the\\:\\ 0\\.003638139071148047\ \(0\)\
\-\ with\\:\\ 0\\.003079057265523414\ \(0\)\
\-\ \\.\\:\\ 0\\.0014012974775268266\ \(0\)\
